THAILAND: YOUR
BIOTECHNOLOGY/BIOMEDICAL PARTNER
|
As a
destination for biotechnology research, development and
outsourcing, Thailand combines the best of China and India while
avoiding many of the problems that plague both. Thailand has a
surplus
of skilled and experienced technicians and lab workers at less than a
quarter the cost of the United States, while avoiding the labor
shortages and turnover of India or the rampant theft of intellectual
property in China. Office, wet lab and home rentals, utilities and
service contract fees are a fraction of other regional centers like
South Korea and Singapore.
With strong intellectual property protection
and rule of law,
Thailand is also an excellent location for clinical trials, regional
research centers and regional sales offices for U.S. and other
companies to reach the Asian market. Thailand is renowned as an
excellent hub for firms looking to expand their market opportunities
into Asia, providing services to Japan, China, India and SE Asia.
Many
of these companies have chosen Thailand’s Science Park (TSP), a modern
campus complex located between two of Thailand’s most prestigious
Universities in the suburbs of Bangkok.
|
Further, the Thai government offers an unbeatable set of incentives,
including an eight-year full tax holiday and 50% for another five
years.
Thailand is the world’s undisputed leader in medical tourism, with over
1.4 million foreign patients and with more than double the foreign
patients of the next competitor – India. Patients coming to Thailand
for everything from open heart surgery to root canals or just a
physical exam are amazed to find facilities that rival or surpass those
of the United States, for a quarter the price. Further, the western
education of these doctors and strong technology infrastructure in both
treatment and record-keeping make Thailand both an affordable and
reliable destination for clinical trials of any stage and for
translational research.
Thailand has a great deal to offer the world, combining a high-tech
infrastructure and talent pool with low costs and a supportive
government. An example of one company that has taken advantage of this
is Maine Biotechnology
Services, Inc., (MBS) which offers its
immunobiological products and services worldwide and has had customers
in Europe since the 1990s and in Asia since early 2000. MBS’
management recognized the tremendous growth opportunities that exist in
Asia. After much study, MBS decided that Thailand would be an
excellent choice for locating its first satellite facility. This
is located at the Thailand Science Park. At this facility, MBS now has
access to reasonably priced laboratory space and highly trained
personnel. The Park offers all the necessities needed to launch a
satellite operation with a range of choices from small office space to
large pilot plants. As Thailand’s biotechnology and medical tourism
sectors continue to grow strongly, it is creating opportunities for
U.S. and other companies which your company should research.
About Maine
Biotechnology Services (MBS)
Maine Biotechnology Services, Inc, (MBS) is pleased to announce the
opening of its first satellite facility at the Thailand Science Park in
Pathunthani, Thailand. MBS, founded in 1990 and based in
Portland, Maine, USA, is a contract developer and manufacturer of
monoclonal and polyclonal antibodies. Since its inception, MBS
has been providing its products and services to the world-wide
biopharmaceutical and diagnostic markets. More recently, MBS has
increased its presence in the Asian market. To meet the needs of
its Asian customer base, MBS has opened a facility in Thailand to
better serve this expanding market. For more information, please
go to www.mainebiotechnology.com
|
Quote:
“For a small
biotechnology company from Portland, Maine, Maine Biotechnology
Service, Inc., found Runckel &
Associates and Delphi
Health Services to be an exemplary guiding light in the maze of
issues that face a company trying to expand its operations in
Asia.
Thailand became a
logical and doable choice for MBS due to the diligence and expertise of
Runckel and Delphi.”
-Joseph Chandler, Ph.D. President,
Maine Biotechnology Services, Inc.
|
About Delphi Health
Services, Ltd.
The next wave of outsourcing in
biotechnology, with firms short
of staff in the U.S. and plentiful, cheap and well-trained technicians
in several Asian destinations.
Delphi Health Services provides a turn-key solution for western firms
seeking to establish a facility in Thailand. Our staff arranges
all renovations or construction for your new facility, interviews and
hires staff, orders and imports equipment, sets up your computer system
with video conferencing to your U.S. Offices, clears all permits, legal
and accounting issues and deals with any other bureaucratic or cultural
barriers you may face. You provide us with detailed
specifications, and we do the rest. For more information, go to www.DelphiHealthServices.com
|
More
of our useful articles:
|
About
the Author:
Christopher
W. Runckel, a former senior US diplomat who served in many counties in
Asia, is a graduate of the University of Oregon and Lewis and Clark Law
School. He served as Deputy General Counsel of President Gerald Ford’s
Presidential Clemency Board. Mr. Runckel is the principal and founder
of Runckel & Associates, a Portland, Oregon based consulting
company that assists businesses expand business opportunities in Asia.
(www.business-in-asia.com)
Until
April of 1999, Mr. Runckel was Minister-Counselor of the US Embassy in
Beijing, China. Mr. Runckel lived and worked in Thailand for over six
years. He was the first permanently assigned U.S. diplomat to return to
Vietnam after the Vietnam War. In 1997, he was awarded the U.S.
Department of States highest award for service, the Distinguished Honor
Award, for his contribution to improving U.S.-Vietnam relations. Mr.
Runckel is one of only two non-Ambassadors to receive this award in the
200-year history of the U.S. diplomatic service.
|
